secwatch.observer — SEC 8-K summary
======================================

Issuer:     XWELL, Inc. (XWEL)
CIK:        0001410428
Form:       8-K
Filed at:   2026-10-08T00:41:21+00:00
Accession:  0001104659-26-114456
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.35
Item codes: 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

XpresTest repurchases 279.5 RSAs for $2.7M ahead of sale; XWELL now owns 100% of subsidiary
--------------------------------------------------------------------------------

- XpresTest, Inc., a XWELL subsidiary, bought back 279.5 restricted stock awards for about $2.7M cash, or $9,634.09 per share; no XpresTest RSAs remain outstanding.
- Chairman Bruce T. Bernstein received $1,030,847.61 for 107 RSAs; CEO Ezra T. Ernst $529,874.94 for 55; CFO Ian Brown $96,340.90 for 10, five of which vested at repurchase.
- The $9,634.09 per-share price matches the value Buyer Express Wellness Group and XWELL agreed for the RSAs under the July 6, 2026 Securities Purchase Agreement.
- All previously unvested RSAs became fully vested; the other 107.5 shares were held by five current or former employees and service providers.
- Paid early with Buyer consent, so these amounts will not count toward XWELL's unpaid sale expenses that would otherwise cut the Buyer's purchase price dollar-for-dollar.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1410428/000110465926114456/0001104659-26-114456-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1410428/000110465926114456/tm2621012d3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-114456

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer